Literature DB >> 11263495

The yeast mitotic cyclin Clb2 cannot substitute for S phase cyclins in replication origin firing.

A D Donaldson1.   

Abstract

Cyclin-dependent kinases (CDKs) drive the cell cycle, central to which is the accurate control of chromosome replication. In Saccharomyces cerevisiae, six closely related B-type cyclins (Clb1-6) drive the events of S phase and mitosis. Either Clb5 or Clb6 can activate early-firing replication origins, whereas only Clb5 can activate late origins. Clb1-4 are expressed later in the cell cycle. Whether Clb cyclins differ only in timing of expression, or else impart different kinase specificities is under ongoing investigation. This study shows that the expression of Clb2 during S phase in cells lacking Clb5 failed to rescue late origin activation. Early expression of Clb2 in cells lacking both Clb5 and Clb6 did not activate early origins on schedule to restore the correct S phase entry time. Therefore, Clb2 cannot drive timely activation of either early or late replication origins, demonstrating that Clb2-directed CDK has a specificity distinct from that driven by Clb5 and Clb6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11263495      PMCID: PMC1083780          DOI: 10.1093/embo-reports/kvd108

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  17 in total

1.  Multiple determinants controlling activation of yeast replication origins late in S phase.

Authors:  K L Friedman; J D Diller; B M Ferguson; S V Nyland; B J Brewer; W L Fangman
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

2.  Replication profile of Saccharomyces cerevisiae chromosome VI.

Authors:  K L Friedman; B J Brewer; W L Fangman
Journal:  Genes Cells       Date:  1997-11       Impact factor: 1.891

Review 3.  At the heart of the budding yeast cell cycle.

Authors:  K Nasmyth
Journal:  Trends Genet       Date:  1996-10       Impact factor: 11.639

4.  Flow cytometric analysis of DNA content in budding yeast.

Authors:  S B Haase; D J Lew
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Analysis of replication intermediates by two-dimensional agarose gel electrophoresis.

Authors:  K L Friedman; B J Brewer
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Closing the cell cycle circle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle.

Authors:  A Amon; S Irniger; K Nasmyth
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

7.  CLB5: a novel B cyclin from budding yeast with a role in S phase.

Authors:  C B Epstein; F R Cross
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

8.  Cyclin-B homologs in Saccharomyces cerevisiae function in S phase and in G2.

Authors:  H Richardson; D J Lew; M Henze; K Sugimoto; S I Reed
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

9.  Interaction with calmodulin is required for the function of Spc110p, an essential component of the yeast spindle pole body.

Authors:  D A Stirling; K A Welch; M J Stark
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

10.  A new pair of B-type cyclins from Saccharomyces cerevisiae that function early in the cell cycle.

Authors:  C Kühne; P Linder
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  17 in total

1.  Interaction of the S-phase cyclin Clb5 with an "RXL" docking sequence in the initiator protein Orc6 provides an origin-localized replication control switch.

Authors:  Gwendolyn M Wilmes; Vincent Archambault; Richard J Austin; Matthew D Jacobson; Stephen P Bell; Frederick R Cross
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

2.  Sequential phosphorylation of CST subunits by different cyclin-Cdk1 complexes orchestrate telomere replication.

Authors:  Veena Gopalakrishnan; Cherylin Ruiling Tan; Shang Li
Journal:  Cell Cycle       Date:  2017-06-26       Impact factor: 4.534

3.  Molecular basis of the functional distinction between Cln1 and Cln2 cyclins.

Authors:  Inma Quilis; Juan Carlos Igual
Journal:  Cell Cycle       Date:  2012-08-14       Impact factor: 4.534

4.  Among B-type cyclins only CLB5 and CLB6 promote premeiotic S phase in Saccharomyces cerevisiae.

Authors:  James M DeCesare; David T Stuart
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

5.  Meiosis-specific regulation of the Saccharomyces cerevisiae S-phase cyclin CLB5 is dependent on MluI cell cycle box (MCB) elements in its promoter but is independent of MCB-binding factor activity.

Authors:  Sheetal A Raithatha; David T Stuart
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

6.  Swe1 regulation and transcriptional control restrict the activity of mitotic cyclins toward replication proteins in Saccharomyces cerevisiae.

Authors:  Fangfang Hu; Oscar M Aparicio
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

7.  Method for identifying phosphorylated substrates of specific cyclin/cyclin-dependent kinase complexes.

Authors:  Yinyin Li; Frederick R Cross; Brian T Chait
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

8.  Systematic triple-mutant analysis uncovers functional connectivity between pathways involved in chromosome regulation.

Authors:  James E Haber; Hannes Braberg; Qiuqin Wu; Richard Alexander; Julian Haase; Colm Ryan; Zach Lipkin-Moore; Kathleen E Franks-Skiba; Tasha Johnson; Michael Shales; Tineke L Lenstra; Frank C P Holstege; Jeffrey R Johnson; Kerry Bloom; Nevan J Krogan
Journal:  Cell Rep       Date:  2013-06-06       Impact factor: 9.423

9.  An overview of Cdk1-controlled targets and processes.

Authors:  Jorrit M Enserink; Richard D Kolodner
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

10.  Quantitative analysis of triple-mutant genetic interactions.

Authors:  Hannes Braberg; Richard Alexander; Michael Shales; Jiewei Xu; Kathleen E Franks-Skiba; Qiuqin Wu; James E Haber; Nevan J Krogan
Journal:  Nat Protoc       Date:  2014-07-10       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.